The Intercept @theintercept
Gilead Sciences announced its Covid-19 therapy drug, remdesivir, will cost private insurers $520 for a single vial, hundreds of times its production cost, which researchers have estimated at 93 cents per dose. https://t.co/7SLLixT02c — PolitiTweet.org